FOSL1 and colonic neoplasm: The elucidation of the cellular and molecular mechanisms underlying the enhancement of colon cancer stemness downstream of the IL-6/STAT3/FRA1 signaling axis opens novel opportunities to develop alternative and possibly more effective therapeutic strategies.